Protalix BioTherapeutics, Inc. (DE) Common Stock (NY:PLX)
1.725
-1.165
(-40.31%)
Streaming Delayed Price
Updated: 3:50 PM EDT, May 9, 2025
Add to My Watchlist
All News about Protalix BioTherapeutics, Inc. (DE) Common Stock![]()
Protalix BioTherapeutics: Management Sounds Confident Despite CRL
December 30, 2021
Via Talk Markets
![]() ![]()
Protalix Stock Is Trading Higher On Meeting Request To FDA For Fabry Disease Candidate Application
August 02, 2021
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
Exposures
Product Safety
![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|